Adrenal involvement in multiple endocrine neoplasia type 1: Results of 7 years prospective screening

Langenbeck's Archives of Surgery

Volumn 392, Issue 4, 2007, Pages 437-443

  Waldmann, J ^a   Bartsch, D K ^b   Kann, P H ^a   Fendrich, V ^a   Rothmund, M ^a   Langer, P ^a,c  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b OWL University   (Germany)

^c UNIVERSITY HOSPITAL MARBURG   (Germany)

Author keywords

Adrenal lesion; Multiple endocrine neoplasia type 1; Screening

Indexed keywords

ADRENAL CORTEX ADENOMA; ADRENAL CORTEX CARCINOMA; ADRENALECTOMY; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPUTED TOMOGRAPHIC COLONOGRAPHY; COURSE EVALUATION; CUSHING SYNDROME; DISEASE ASSOCIATION; ENDOSCOPIC ECHOGRAPHY; EXON; FEMALE; FOLLOW UP; GENOTYPE PHENOTYPE CORRELATION; GERM LINE; HUMAN; LAPAROSCOPIC SURGERY; LONG TERM CARE; MALE; MULTIPLE ENDOCRINE NEOPLASIA; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; SAMPLE SIZE; SCREENING TEST; SOMATIC MUTATION; TUMOR VOLUME;

ADOLESCENT; ADRENAL GLAND NEOPLASMS; ADRENALECTOMY; ADULT; AGED; DNA MUTATIONAL ANALYSIS; ENDOSONOGRAPHY; FEMALE; GENOTYPE; GERM-LINE MUTATION; HUMANS; MALE; MIDDLE AGED; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; PHENOTYPE; PREVALENCE; PROSPECTIVE STUDIES;

EID: 34250308015     PISSN: 14352443     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00423-006-0124-7     Document Type: Article

References (46)

1. Chandrasekharappa SC et al (1997) Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 276(5311):404-407
2. Wermer P (1954) Genetic aspects of adenomatosis of endocrine glands. Am J Med 16:363-371
3. Burgess JR, Greenaway TM, Shepherd JJ (1998) Expression of the MEN-1 gene in a large kindred with multiple endocrine neoplasia type 1. J Intern Med 243(6):465-470
4. Darling TN et al (1997) Multiple facial angiofibromas and collagenomas in patients with multiple endocrine neoplasia type 1. Arch Dermatol 133(7):853-857
5. Duh QY et al (1987) Carcinoids associated with multiple endocrine neoplasia syndromes. Am J Surg 154(1):142-148
6. Gibril F et al (2003) Prospective study of thymic carcinoids in patients with multiple endocrine neoplasia type 1. J Clin Endocrinol Metab 88(3):1066-1081
7. Hofmann M et al (1998) Multiple endocrine neoplasia associated with multiple lipomas. Med Klin (Munich) 93(9):546-549
8. Marx S et al (1998) Multiple endocrine neoplasia type 1: clinical and genetic topics. Ann Intern Med 129(6):484-494
9. Lips CJ, Vasen HF, Lamers CB (1984) Multiple endocrine neoplasia syndromes. Crit Rev Oncol Hematol 2(2):117-184
10. Thakker RV (2000) Multiple endocrine neoplasia type 1. Endocrinol Metab Clin North Am 29(3):541-567
11. Carty SE et al (1998) The variable penetrance and spectrum of manifestations of multiple endocrine neoplasia type 1. Surgery 124(6):1106-1113; discussion 1113-4
12. Skogseid B et al (1992) Clinical and genetic features of adrenocortical lesions in multiple endocrine neoplasia type 1. J Clin Endocrinol Metab 75(1):76-81
13. Skogseid B et al (1995) Adrenal lesion in multiple endocrine neoplasia type 1. Surgery 118(6):1077-1082
14. Burgess JR et al (1996) Adrenal lesions in a large kindred with multiple endocrine neoplasia type 1. Arch Surg 131(7):699-702
15. Langer P et al (2002) Adrenal involvement in multiple endocrine neoplasia type 1. World J Surg 26(8):891-896
16. Barzon L et al (2001) Multiple endocrine neoplasia type 1 and adrenal lesions. J Urol 166(1):24-27
17. Gibril F et al (2004) Multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: a prospective study of 107 cases and comparison with 1009 cases from the literature. Medicine (Baltimore) 83(1):43-83
18. Cadiot G et al (1999) Prognostic factors in patients with Zollinger-Ellison syndrome and multiple endocrine neoplasia type 1. Groupe d'Etude des Neoplasies Endocriniennes Multiples (GENEM and groupe de Recherche et d'Etude du Syndrome de Zollinger-Ellison (GRESZE). Gastroenterology 116(2):286-293
19. Ballard HS, Fame B, Hartstock RJ (1964) Familial endocrine adenoma-peptic ulcer complex. Medicine (Baltimore) 43:481-516
20. Croisier JC, Azerad E, Lubetzki J (1971) L'adenomatose polyendocrinienne (syndrome de Wermer). Semin Hop Paris 47:494-525
21. Dobbie JW (1969) Adrenocortical nodular hyperplasia: the ageing adrenal. J Pathol 99:1-18
22. Kokko JP, Brown TC, Berman MM (1967) Adrenal adenoma and hypertension. Lancet 1(7488):468-470
23. Hedeland H, Ostberg G, Hokfelt B (1968) On the prevalence of adrenocortical adenomas in an autopsy material in relation to hypertension and diabetes. Acta Med Scand 184(3):211-214
24. Anonymous (2002) NIH state-of-the-science statement on management of the clinically inapparent adrenal mass ("incidentaloma"). NIH Consens State Sci Statements 19(2):1-25
25. Thompson GB, Young WF Jr (2003) Adrenal incidentaloma. Curr Opin Oncol 15(1):84-90
26. Kloos RT et al (1997) Diagnostic dilemma of small incidentally discovered adrenal masses: role for 131I-6beta-iodomethyl-norcholesterol scintigraphy. World J Surg 21(1):36-40
27. Commons RR, Callaway CP (1948) Adenomas of the adrenal cortex. Arch Intern Med 81:37-41
28. Reinhard C, Saeger W, Schubert B (1996) Adrenocortical nodules in post-mortem series. Development, functional significance, and differentiation from adenomas. Gen Diagn Pathol 141(3-4):203-208
29. Granger P, Genest J (1970) Autopsy study of adrenals in unselected normotensive and hypertensive patients. Can Med Assoc J 103(1):34-36
30. Brandi ML et al (2001) Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 86(12):5658-5671
31. Skogseid B et al (1996) Surgery for asymptomatic pancreatic lesion in multiple endocrine neoplasia type I. World J Surg 20(7):872-876; discussion 877
32. Brandi ML et al (1987) Familial multiple endocrine neoplasia type I: a new look at pathophysiology. Endocr Rev 8(4):391-405
33. Trump D et al (1996) Clinical studies of multiple endocrine neoplasia type 1 (MEN1). Q J Med 89(9):653-669
34. Chico A et al (2000) Genetic, clinical, and biochemical analysis of unrelated Spanish families with multiple endocrine neoplasia type I. Endocr Pract 6(1):13-19
35. Agarwal SK et al (1999) Menin interacts with the AP1 transcription factor JunD and represses JunD-activated transcription. Cell 96(1):143-152
36. Kim YS et al (1999) Stable overexpression of MEN1 suppresses tumorigenicity of RAS. Oncogene 18(43):5936-5942
37. Heppner C et al (2001) The tumor suppressor protein menin interacts with NF-kappaB proteins and inhibits NF-kappaB-mediated transactivation. Oncogene 20(36):4917-4925
38. Zwermann O et al (2000) Multiple endocrine neoplasia type 1 gene expression is normal in sporadic adrenocortical tumors. Eur J Endocrinol 142(6):689-695
39. Schulte KM et al (1999) MEN I gene mutations in sporadic adrenal adenomas. Hum Genet 105(6):603-610
40. Gortz B et al (1999) MEN1 gene mutation analysis of sporadic adrenocortical lesions. Int J Cancer 80(3):373-379
41. Heppner C et al (1999) MEN1 gene analysis in sporadic adrenocortical neoplasms. J Clin Endocrinol Metab 84(1):216-219
42. Crabtree JS et al (2001) A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors. Proc Natl Acad Sci USA 98(3):1118-1123
43. Tomassetti P et al (1995) Chromosomal instability in multiple endocrine neoplasia type 1. Cytogenetic evaluation with DEB test. Cancer Genet Cytogenet 79(2):123-126
44. Scappaticci S et al (1992) Cytogenetics of multiple endocrine neoplasia syndrome. II. Chromosome abnormalities in an insulinoma and a glucagonoma from two subjects with MEN1. Cancer Genet Cytogenet 63(1):17-21
45. Pannett AA, Thakker RV (2001) Somatic mutations in MEN type 1 tumors, consistent with the Knudson "two-hit" hypothesis. J Clin Endocrinol Metab 86(9):4371-4374
46. Bartsch DK et al (2000) Pancreaticoduodenal endocrine tumors in multiple endocrine neoplasia type 1: surgery or surveillance? Surgery 128(6):958-966